2nd Medical Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
2nd Medical Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania. .
J Gastrointestin Liver Dis. 2024 Sep 29;33(3):316-322. doi: 10.15403/jgld-5834.
Celiac disease (CD) is an autoimmune disorder that targets the small intestine, triggered by the ingestion of gluten in genetically predisposed individuals, causing damage to the villi and impairing nutrient absorption. Despite increased awareness and improved diagnostic techniques, CD remains significantly underdiagnosed, with many individuals suffering from unexplained symptoms or misdiagnosed conditions. This study aims to investigate the prevalence and demographic characteristics of CD in a Romanian population using rapid diagnostic tests followed by histological confirmation.
This cross-sectional study aimed to determine the prevalence of CD in Romania using the BIOHIT Celiac Quick Test among adult participants recruited from tertiary healthcare centers and medical institutions. The prevalence of CD was calculated by dividing the number of confirmed positive cases by the total number of participants, with further evaluation including endoscopy and histological examination for those with positive quick test results. To our knowledge, this is the first prospective study in Romania to assess the prevalence of CD using a serological test.
Out of 713 participants from Romania, 9 tested positive for CD using a rapid diagnostic test, confirmed by histological examination, resulting in a prevalence rate of 1.26%. The mean age of the CD-positive group was significantly younger (30.3 years) compared to the general population (49.2 years), and they had a lower mean BMI (22.2 vs. 28.1). Most CD-positive patients were female (66.7%) and resided in urban areas (55.6%).
Our study found the prevalence of CD in a Romanian population to be slightly higher than the global average, highlighting the effectiveness of rapid diagnostic tests followed by histological confirmation. The significant regional variability in CD prevalence suggests the need for further research into environmental, dietary, and genetic factors, along with enhanced awareness and improved diagnostic protocols to better manage and prevent long-term complications of CD.
乳糜泻(CD)是一种自身免疫性疾病,针对小肠,由遗传易感性个体摄入麸质触发,导致绒毛损伤和营养吸收受损。尽管对 CD 的认识有所提高且诊断技术有所改进,但 CD 的诊断仍明显不足,许多患者存在不明原因的症状或误诊。本研究旨在使用快速诊断测试结合组织学确认,研究罗马尼亚人群中 CD 的患病率和人口统计学特征。
本横断面研究旨在通过在罗马尼亚的三级医疗中心和医疗机构招募的成年参与者中使用 BIOHIT 乳糜泻快速测试,确定 CD 的患病率。通过将确诊阳性病例数除以总人数计算 CD 的患病率,对快速测试阳性结果的患者进行进一步评估,包括内镜检查和组织学检查。据我们所知,这是罗马尼亚首次使用血清学测试评估 CD 患病率的前瞻性研究。
在来自罗马尼亚的 713 名参与者中,有 9 名使用快速诊断测试检测出 CD 阳性,经组织学检查证实,患病率为 1.26%。CD 阳性组的平均年龄明显较年轻(30.3 岁),而一般人群的平均年龄较大(49.2 岁),且平均 BMI 较低(22.2 与 28.1)。大多数 CD 阳性患者为女性(66.7%),居住在城市地区(55.6%)。
我们的研究发现罗马尼亚人群中 CD 的患病率略高于全球平均水平,这突出了快速诊断测试结合组织学确认的有效性。CD 患病率的显著区域差异表明,需要进一步研究环境、饮食和遗传因素,以及提高认识和改进诊断方案,以更好地管理和预防 CD 的长期并发症。